MustGrow Biologics Isolates Third Molecule From Mustard Plant
MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different molecules. The firm this morning
Read more
Biotech
Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing
Wednesday, Antibe Therapeutics (TSX: ATE) announced that they closed their bought deal financing. The bought deal was for 6.7 million
Read more
Relay Medical’s Joint Venture Selected To Deploy COVID-19 Testing Platform At Toronto Pearson Airport
Relay Medical (CSE: RELA) this afternoon announced that it has seen its joint venture, Fionet Rapid Response Group, engaged by
Read more
Antibe Therapeutics To Raise $35.1 Million In Bought Deal
Money continues to be raised at a feverish pace in the capital markets, with Antibe Therapeutics (TSX: ATE) the latest
Read more
Willow Biosciences: Jazz Pharma – GW Pharma Merger Has Positive Read-Through For Company
Last week’s announcement that Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has agreed to buy GW Pharmaceuticals (NASDAQ: GWPH) for US$7.2 billion
Read more
Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50
Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm in China. The deal includes
Read more
Revive Therapeutics Provides Market Update On Cannabinoid Related Research
Revive Therapeutics (CSE: RVV) this morning provided an update in connection with its ongoing cannabinoid pharmaceuticals program. More specifically, the
Read more
MustGrow Achieves 100% Economical Control Of Panama Disease, Moves To Field Trials
MustGrow Biologics (CSE: MGRO) has seen further validation of its proprietary mustard derived biopesticide following further laboratory results. The latest
Read more
MustGrow Announces 100% Control Of Root Rot Disease With Patented Biopesticide
MustGrow Biologics (CSE: MGRO) has seen further success with its mustard-derived biopesticide, this morning announcing that third party independent testing
Read more
Willow Biosciences Looks To Launch Biosynthesized THC In Canadian Market
Willow Biosciences (TSX: WLLW) this morning had a major announcement, with the company announcing that it has advanced its work
Read more